Expression of LMP and EBNA genes in Epstein-Barr virus-associated lymphomas in Hu-PBL/SCID mice

Tang,Yunlian; Lu,Suli; Gan,Xiaoning; Liu,Fang; Zhang,Yang; Luo,Chunyan; Pan,Yuxia; Hong,Li; Gan,Ruliang

doi:10.3892/or.2015.4401

Expression of LMP and EBNA genes in Epstein-Barr virus-associated lymphomas in Hu-PBL/SCID mice

Authors:
- Yunlian Tang
- Suli Lu
- Xiaoning Gan
- Fang Liu
- Yang Zhang
- Chunyan Luo
- Yuxia Pan
- Li Hong
- Ruliang Gan
View Affiliations

Affiliations: Cancer Research Institute, College of Medicine, University of South China, Hengyang, Hunan 421001, P.R. China, College of Medicine, University of South China, Hengyang, Hunan 421001, P.R. China
Published online on: November 5, 2015 https://doi.org/10.3892/or.2015.4401
Pages: 905-911

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Transplantation of peripheral blood lymphocytes (PBLs) from healthy humans with latent Epstein-Barr virus (EBV) infection into severe combined immunodeficiency (SCID) mice results in development of EBV-associated human B-cell lymphoma. However, the expression of EBV genes in relation to lymphoma development has not been reported. We investigated latent membrane protein (LMP) and EBV nuclear antigen (EBNA) gene expression in PBLs from EBV-positive blood donors and induced-lymphoma cells from SCID mice to elucidate the functions and effects of the EBV genome in the occurrence and development of lymphoma. PBLs were isolated from 9 healthy blood donors and transplanted into SCID mice. Gene expression levels of LMP-1, LMP-2A, and LMP-2B and EBNA-1, EBNA-2, EBNA-3A, EBNA-3B, EBNA-3C and EBNA-LP were monitored by real-time quantitative-polymerase chain reaction (qRT-PCR) in cells from nine EBV-induced lymphomas and in matched lymphocytes from healthy subjects. LMP-1, EBNA-1 and EBNA-2 protein levels were detected by western blotting. As a result, LMP-1, LMP-2A and LMP-2B mRNA levels were upregulated 256-, 38- and 331-fold, respectively, in the EBV-induced lymphoma cells compared with the controls, while EBNA-1 and EBNA-3A mRNA levels were upregulated 1157- and 1154-fold, respectively. EBNA-2, EBNA-3B, EBNA-3C and EBNA-LP mRNAs were detected in lymphoma cells, but not in lymphocytes from EBV-positive blood donors. LMP-1 and EBNA-2 proteins were not expressed in lymphocytes from EBV-positive blood donors, according to western blotting. Weak EBNA-1 expression was observed in lymphocytes from blood donors with latent EBV infection, while LMP-1, EBNA-1 and EBNA-2 protein levels were significantly upregulated in EBV-induced lymphoma cells, consistent with mRNA expression levels detected by qRT-PCR. In conclusion, LMP-1, LMP-2A, LMP-2B, EBNA-1 and EBNA-3A were upregulated in EBV-induced lymphoma cells, while EBNA-2, EBNA-3B, EBNA-3C and EBNA-LP were absent in lymphocytes from humans with latent EBV infection, but were positively expressed in EBV-induced lymphoma cells.

View Figures

View References

1	Lan K, Verma SC, Murakami M, Bajaj B and Robertson ES: Epstein-Barr virus (EBV): Infection, propagation, quantitation, and storage. Curr Protoc Microbiol Chapter 14. Unit 14E.2. 2007. View Article : Google Scholar
2	Rasul AE, Nagy N, Sohlberg E, Ádori M, Claesson HE, Klein G and Klein E: Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells. J Immunol Methods. 385:60–70. 2012. View Article : Google Scholar : PubMed/NCBI
3	Tang Y, Luo C, Cheng A, Lu S, Xu J, Fu T and Gan R: Expression of latent membrane proteins in Epstein Barr virus-transformed lymphocytes in vitro. Mol Med Rep. 10:1117–1121. 2014.PubMed/NCBI
4	Gan R, Yin Z, Liu T, Wang L, Tang Y and Song Y: Cyclosporine A effectively inhibits graft-versus-host disease during development of Epstein-Barr virus-infected human B cell lymphoma in SCID mouse. Cancer Sci. 94:796–801. 2003. View Article : Google Scholar : PubMed/NCBI
5	Gan R, Xie X, He J, Liu X, Hong L, Tang Y, Liu F and Xie H: Gene analysis of Epstein-Barr virus-associated lymphomas in Hu-Pbl/SCID chimeras. Tumori. 96:465–472. 2010.PubMed/NCBI
6	Klein E, Kis LL and Klein G: Epstein-Barr virus infection in humans: From harmless to life endangering virus-lymphocyte interactions. Oncogene. 26:1297–1305. 2007. View Article : Google Scholar : PubMed/NCBI
7	Canaan A, Haviv I, Urban AE, Schulz VP, Hartman S, Zhang Z, Palejev D, Deisseroth AB, Lacy J, Snyder M, et al: EBNA1 regulates cellular gene expression by binding cellular promoters. Proc Natl Acad Sci USA. 106:22421–22426. 2009. View Article : Google Scholar
8	Klein G, Klein E and Kashuba E: Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes. Biochem Biophys Res Commun. 396:67–73. 2010. View Article : Google Scholar : PubMed/NCBI
9	Zhang B, Kracker S, Yasuda T, Casola S, Vanneman M, Hömig-Hölzel C, Wang Z, Derudder E, Li S, Chakraborty T, et al: Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model. Cell. 148:739–751. 2012. View Article : Google Scholar : PubMed/NCBI
10	Ramakrishnan R, Donahue H, Garcia D, Tan J, Shimizu N, Rice AP and Ling PD: Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas. PLoS One. 6:e272712011. View Article : Google Scholar : PubMed/NCBI
11	Tomita M, Dewan MZ, Yamamoto N, Kikuchi A and Mori N: Epstein-Barr virus-encoded latent membrane protein 1 activates beta-catenin signaling in B lymphocytes. Cancer Sci. 100:807–812. 2009. View Article : Google Scholar : PubMed/NCBI
12	Lee CW, Leu SJ, Tzeng RY, Wang SF, Tsai SC, Sun KH, Chen RH and Huang JC: Latent membrane protein 1 of Epstein-Barr virus regulates death-associated protein kinase 1 in lymphoblastoid cell line. Virology. 413:19–25. 2011. View Article : Google Scholar : PubMed/NCBI
13	Rechsteiner MP, Berger C, Zauner L, Sigrist JA, Weber M, Longnecker R, Bernasconi M and Nadal D: Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection. J Virol. 82:1739–1747. 2008. View Article : Google Scholar :
14	Bultema R, Longnecker R and Swanson-Mungerson M: Epstein-Barr virus LMP2A accelerates MYC-induced lymphomagenesis. Oncogene. 28:1471–1476. 2009. View Article : Google Scholar : PubMed/NCBI
15	Wasil LR, Tomaszewski MJ, Hoji A and Rowe DT: The effect of Epstein-Barr virus latent membrane protein 2 expression on the kinetics of early B cell infection. PLoS One. 8:e540102013. View Article : Google Scholar : PubMed/NCBI
16	Guasparri I, Bubman D and Cesarman E: EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression. Blood. 111:3813–3820. 2008. View Article : Google Scholar : PubMed/NCBI
17	Vrazo AC, Chauchard M, Raab-Traub N and Longnecker R: Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice. PLoS Pathog. 8:e10026622012. View Article : Google Scholar : PubMed/NCBI
18	Do NV, Ingemar E, Phi PT, Jenny A, Chinh TT, Zeng Y and Hu L: A major EBNA1 variant from Asian EBV isolates shows enhanced transcriptional activity compared to prototype B95.8. Virus Res. 132:15–24. 2008. View Article : Google Scholar
19	Chen YL, Liu CD, Cheng CP, Zhao B, Hsu HJ, Shen CL, Chiu SJ, Kieff E and Peng CW: Nucleolin is important for Epstein-Barr virus nuclear antigen 1-mediated episome binding, maintenance, and transcription. Proc Natl Acad Sci USA. 111:243–248. 2014. View Article : Google Scholar
20	Liu X, Tang J, Wang M, Ma Q and Wang Y: Visual detection and evaluation of latent and lytic gene expression during Epstein-Barr virus infection using one-step reverse transcription loop-mediated isothermal amplification. Int J Mol Sci. 14:23922–23940. 2013. View Article : Google Scholar : PubMed/NCBI
21	Daskalogianni C, Pyndiah S, Apcher S, Mazars A, Manoury B, Ammari N, Nylander K, Voisset C, Blondel M and Fåhraeus R: Epstein-Barr virus-encoded EBNA1 and ZEBRA: Targets for therapeutic strategies against EBV-carrying cancers. J Pathol. 235:334–341. 2015. View Article : Google Scholar
22	Pagès F, Galon J, Karaschuk G, Dudziak D, Camus M, Lazar V, Camilleri-Broët S, Lagorce-Pagès C, Lebel-Binay S, Laux G, et al: Epstein-Barr virus nuclear antigen 2 induces interleukin-18 receptor expression in B cells. Blood. 105:1632–1639. 2005. View Article : Google Scholar
23	Rowe M, Raithatha S and Shannon-Lowe C: Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: Implications for stromal effects on virus-host interactions. J Virol. 88:12065–12076. 2014. View Article : Google Scholar : PubMed/NCBI
24	Yue W, Gershburg E and Pagano JS: Hyperphosphorylation of EBNA2 by Epstein-Barr virus protein kinase suppresses trans-activation of the LMP1 promoter. J Virol. 79:5880–5885. 2005. View Article : Google Scholar : PubMed/NCBI
25	Konforte D, Simard N and Paige CJ: Interleukin-21 regulates expression of key Epstein-Barr virus oncoproteins, EBNA2 and LMP1, in infected human B cells. Virology. 374:100–113. 2008. View Article : Google Scholar : PubMed/NCBI
26	Young P, Anderton E, Paschos K, White R and Allday MJ: Epstein-Barr virus nuclear antigen (EBNA) 3A induces the expression of and interacts with a subset of chaperones and co-chaperones. J Gen Virol. 89:866–877. 2008. View Article : Google Scholar : PubMed/NCBI
27	Chen A, Zhao B, Kieff E, Aster JC and Wang F: EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines. J Virol. 80:10139–10150. 2006. View Article : Google Scholar : PubMed/NCBI
28	Tursiella ML, Bowman ER, Wanzeck KC, Throm RE, Liao J, Zhu J and Sample CE: Epstein-Barr virus nuclear antigen 3A promotes cellular proliferation by repression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1. PLoS Pathog. 10:e10044152014. View Article : Google Scholar : PubMed/NCBI
29	Saha A and Robertson ES: Impact of EBV essential nuclear protein EBNA-3C on B-cell proliferation and apoptosis. Future Microbiol. 8:323–352. 2013. View Article : Google Scholar : PubMed/NCBI
30	Portal D, Zhou H, Zhao B, Kharchenko PV, Lowry E, Wong L, Quackenbush J, Holloway D, Jiang S, Lu Y, et al: Epstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2. Proc Natl Acad Sci USA. 110:18537–18542. 2013. View Article : Google Scholar : PubMed/NCBI
31	Portal D, Zhao B, Calderwood MA, Sommermann T, Johannsen E and Kieff E: EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding. Proc Natl Acad Sci USA. 108:7808–7813. 2011. View Article : Google Scholar : PubMed/NCBI
32	Yokoyama A, Tanaka M, Matsuda G, Kato K, Kanamori M, Kawasaki H, Hirano H, Kitabayashi I, Ohki M, Hirai K, et al: Identification of major phosphorylation sites of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP): Ability of EBNA-LP to induce latent membrane protein 1 cooperatively with EBNA-2 is regulated by phosphorylation. J Virol. 75:5119–5128. 2001. View Article : Google Scholar : PubMed/NCBI